Everest Medicines Ltd at Morgan Stanley Biotech Without Borders Series Transcript
(Operator Instructions)
So we're very pleased to have Mr. Ian Wu, President and Chief Financial Officer of Everest Medicine joining us today. (Operator Instructions)
Questions & Answers
So first question, Ian, on the partnership rationale and the operating model. So with the Trivia transaction now closed, what made Trivia the right global partner for this asset and how will the two companies divide development responsibilities, indication prioritisation and decision-making from here?
I think, first and foremost, we really believe Trivir, there is a very strong strategic fit with Everest.
Trivir is a recognized leader in rare kidney disease.
They have very established clinical development, regulatory, and commercial capabilities focused specifically on nephrology.
I think as part of our interactions and due diligence on Trivir, we noticed that they have, the number of people that they
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
